Bayer, Atara Biotherapeutics to partner for mesothelin-targeted CAR T-cell therapies
The agreement includes the development candidate ATA3271, an armored allogeneic T-cell immunotherapy, and an autologous version,…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.